1. Streamlining lung cancer management in Nova Scotia amid COVID-19: pooled triaging for expedited curative-intent oncologic surgery
- Author
-
Patel, Pooja, Brownstone, Rheann, Cruickshank, Brianne, Garagan, Connor, Manos, Daria, French, Daniel, Wallace, Alison, and Plourde, Madelaine
- Subjects
Epidemics -- Influence -- Control -- Canada ,Chest -- Surgery ,Lung cancer -- Care and treatment -- Diagnosis ,Triage (Medicine) -- Methods ,Nova Scotia -- Health aspects - Abstract
Background: The effect of the COVID-19 pandemic on the diagnosis and management of lung cancer in Canada is not fully understood. We sought to quantify the provincial volume of diagnostic imaging, thoracic surgeon referrals, time to surgery after referral, and pathologic staging for curative surgery in the context of the pandemic, as well as explore the effect of a pooled patient model, which was implemented to prioritize surgeries for lung cancer and mitigate the effects of the pandemic. Methods: We conducted a retrospective cohort study of patients who underwent diagnostic imaging in Nova Scotia and were subsequently referred to a thoracic surgeon at the province's only tertiary care centre for surgical management of their primary lung cancer before (Mar. 1, 2019, to Feb. 29, 2020) and during (Mar. 1, 2020, to Feb. 28, 2021) the COVID-19 pandemic. We conducted a survey to capture the patient and surgeon experience with a pooled patient model of managing surgical oncology cases. Results: Compared with the pre-COVID-19 period, the overall volume of chest radiography and chest computed tomography decreased by 30.9% (p < 0.001) and 18.7% (p = 0.002), respectively, in the COVID-19 period. Thoracic surgeon referrals, operative approach, extent of resection, length of hospital stay, and pathologic staging did not significantly differ. Time from referral to surgery was significantly shorter during the COVID-19 period (mean 196.8 d v. 157.9 d, p = 0.04). A pooled patient approach contributed to positive patient satisfaction. Conclusion: The COVID-19 pandemic was associated with reductions in rates of diagnostic imaging and referrals to thoracic surgeons for management of pulmonary cancer. A pooled patient model was used to mitigate the effects of the pandemic on lung cancer management and was positively received by patients. An extended study period is needed to determine the full effect of this redistribution of resources. Contexte : L'effet de la pand mie de COVID-19 sur le diagnostic et la prise en charge du cancer du poumon au Canada n'est pas enti rement compris. Nous avons voulu conna tre le volume provincial d' preuves d'imagerie diagnostique et de demandes de consultation en chirurgie thoracique, de m me que l'intervalle entre les consultations et les chirurgies et le stade de la maladie justiciable d'une chirurgie vis e curative dans le contexte de la pand mie, en plus d'explorer l'effet d'un mod le de cas group s pour tablir l'ordre de priorit des chirurgies pour le cancer du poumon et att nuer les effets de la pand mie. M thodes : Nous avons proc d une tude de cohorte r trospective aupr s des personnes ayant subi des preuves d'imagerie diagnostiques en Nouvelle- cosse et adress es en chirurgie thoracique dans le seul tablissement de soins tertiaires de la province pour une prise en charge chirurgicale de leur n oplasie pulmonaire primitive avant (du 1er mars 2019 au 29 f vrier 2020) et durant (du 1er mars 2020 au 28 f vrier 2021) la pand mie de COVID-19. Nous avons r alis un sondage sur l'exp rience des malades et des chirurgiennes et chirurgiens dans le cadre d'un mod le de cas group s pour la prise en charge chirurgicale en oncologie. R sultats : Comparativement la p riode pr -COVID-19, le volume global des radiographies pulmonaires et des tomodensitom tries thoraciques a diminu de 30,9% (p < 0,001) et de 18,7% (p = 0,002), respectivement, durant la p riode de COVID-19. Les consultations en chirurgie thoracique, l'approche chirurgicale, l'ampleur de la r section, la dur e du s jour hospitalier et la stadification de la maladie n'ont pas diff r significativement. L'intervalle entre les consultations et les chirurgies a t significativement plus bref durant la p riode de COVID-19 (moyenne 196,8 j c. 157,9 j, p = 0,04). Le mod le de priorisation des cas group s a contribu favorablement la satisfaction des malades. Conclusion : La pand mie de COVID-19 a t associ e une r duction des taux d' preuves d'imagerie diagnostique et de demandes de consultation en chirurgie thoracique pour la prise en charge du cancer du poumon. Un mod le de priorisation de cas group s a servi att nuer les effets de la pand mie sur la prise en charge du cancer du poumon et a t accueilli favorablement par les malades. Un volet de prolongation est n cessaire pour mesurer tout l'effet de cette redistribution des ressources., Lung cancer is the leading global cause of cancer-related deaths among both males and females. (1) In Canada, lung cancer has the highest cancer mortality; Nova Scotia has one of [...]
- Published
- 2024
- Full Text
- View/download PDF